Christopher J. SpadaroAssociateProskauer Rose LLPWebsitewww.proskauer.comOrganization ProfileFull ProfileBlogwww.proskauer.com/insightsConnectEmailTwitterLinkedIn212-969-3259 Professional Biography Christopher Spadaro is an associate in the Litigation Department. Related Practices Litigation Admissions & Qualifications New York More Legal and Business Bylines From Christopher J. Spadaro Pre-Election Drug Pricing Regulation Efforts: Where Does Congress Stand? - (Posted On Wednesday, September 30, 2020) HHS Can’t Force Disclosure of Drug Prices in Ads with “Blunderbuss” Rule - (Posted On Friday, September 11, 2020) Current Legal Analysis McDermott+ Check-Up: September 12, 2025 by: Debra Curtis , Kristen O’Brien Rule Abandoned, Crackdown Continues: The Federal Trade Commission’s New Non-compete Strategy by: Michael S. Wise , Martin J. Mackowski Jurisdictional Authority in Transnational Litigation: The Greenpeace and Energy Transfer Dispute by: Brady Pelton Nasdaq Proposes Rule Changes to Enable Trading of Tokenized Securities by: Nathan M. Iacovino , Barbara A. Jones Ofcom Updates Guidance on Protecting People from Online Suicide and Self-Harm Material Amidst Investigation into Suicide Forum by: Terry Green EisnerAmper UAE Joins EisnerAmper Global Network by: INSIDE Public Accounting Merger of Leading Firms Creates National Platform Under Richey May Brand by: INSIDE Public Accounting FDA on the Offense! Targeting Pharmaceutical Company Drug Advertising in Wave of Enforcement Actions by: Kyle Y. Faget , Jessa Boubker F-Word as a Trademark? Federal Circuit Leaves the Door Open as it Vacates TTAB’s Decision by: Jennifer A. Van Kirk , Erica R. Halstead The Real Fix for Signature-Based Denials in Immigration Petitions Lies With USCIS by: Sherry Neal Affordable Housing Coalition Says Texas Law Violates State Constitution by: Timothy Keane Eight Essential Steps to Minimize Environmental Liabilities in Industrial Property Transactions by: J. Michael Showalter , Joshua R. More UK OFSI Enforcement Underscores Need for Effective Sanctions Screening and Controls by: Annabel Thomas , Gavin Costelloe Trump’s Federal Trade Commission Abandons Noncompete Ban by: Rachel E. Green FDA Launches Crackdown on Deceptive Drug Advertising and Initiates Rulemaking by: Seth Mailhot Upcoming Events Sep 15-16 2025 Chief Litigation Officer Summit Sep 15-16 2025 US General Counsel Summit Sep 18 2025 Workplace Horizons Extension: Chicago Sep 29-30 2025 Intellectual Property Law Institute 2025 - New York Print
